TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36343050

Group type: EXPERIMENTAL
Intervention: Periorbital transcutaneous electric nerve stimulation (TENS) for 30 minutes, evoking blinking of the right eye 20 times per minute
Number of subjects: 17
Study: 32851421

Group type: EXPERIMENTAL
Intervention: CDP-choline (500 mg) with galantamine (16 mg)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 33577559

Group type: EXPERIMENTAL
Intervention: HIV testing and awareness of serostatus
Number of subjects: 11773

Group type: EXPERIMENTAL
Intervention: Initiation of antiretroviral treatment (ART)
Number of subjects: 11773

Group type: EXPERIMENTAL
Intervention: Loss to follow-up on ART
Number of subjects: 11773

Group type: EXPERIMENTAL
Intervention: WHO stage III/IV AIDS at first clinical visit
Number of subjects: 11773

Group type: EXPERIMENTAL
Intervention: HIV prevalence estimates
Number of subjects: 11773

Group type: EXPERIMENTAL
Intervention: Disparity in awareness of serostatus among individuals <25 years
Number of subjects: 11773
Study: 32740914

Group type: EXPERIMENTAL
Intervention: Probable ADHD
Number of subjects: 1152
Study: 32449336

Group type: EXPERIMENTAL
Intervention: Bilateral erector spinae block at the level of T9
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Bilateral subcostal transversus abdominis block
Number of subjects: 66

Group type: COMPARATOR
Intervention: Opioid analgesia (control group)
Number of subjects: 66
Study: 35190468

Group type: EXPERIMENTAL
Intervention: 10 mL 0.5% bupivacaine plus 133 mg liposomal bupivacaine (LB)
Number of subjects: 70

Group type: COMPARATOR
Intervention: 20 mL of 0.5% bupivacaine
Number of subjects: 70
Study: 33548194

Group type: EXPERIMENTAL
Intervention: CoronaVac 1.5 µg
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: CoronaVac 3 µg
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: CoronaVac 6 µg
Number of subjects: 422

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: CoronaVac 3 µg (phase 1)
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: CoronaVac 6 µg (phase 1)
Number of subjects: 422

Group type: COMPARATOR
Intervention: Placebo (phase 1)
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 422
Study: 32402509

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Definitive high-dose radiation therapy (RT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 0
Study: 35294969

Group type: EXPERIMENTAL
Intervention: Daily multivitamin-multimineral (MVM) supplement
Number of subjects: 21442

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21442
Study: 33587993

Group type: EXPERIMENTAL
Intervention: Advance care planning knowledge (measured by a knowledge scale consisting of seven questions)
Number of subjects: 921

Group type: EXPERIMENTAL
Intervention: Low knowledge
Number of subjects: 921

Group type: EXPERIMENTAL
Intervention: Higher knowledge
Number of subjects: 921
Study: 32069463

Group type: EXPERIMENTAL
Intervention: Nurse-guided Internet-delivered CBT-I (I-CBT-I)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Care-as-usual (Control)
Number of subjects: 134
Study: 35472657

Group type: EXPERIMENTAL
Intervention: Father interpersonal support to mothers
Number of subjects: 681

Group type: EXPERIMENTAL
Intervention: Participation in shared household decision-making
Number of subjects: 681

Group type: EXPERIMENTAL
Intervention: Fathers' direct engagement in stimulation activities with children
Number of subjects: 681

Group type: EXPERIMENTAL
Intervention: Inviting fathers to the program
Number of subjects: 681
Study: 32321536

Group type: EXPERIMENTAL
Intervention: Robotic therapy
Number of subjects: 16

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 16
Study: 36297081

Group type: COMPARATOR
Intervention: CAF*TAU (co‐ingestion of 3 g single dose of taurine and 6 mg/kg of caffeine)
Number of subjects: 20

Group type: COMPARATOR
Intervention: TAU (3 g single dose of taurine)
Number of subjects: 20
Study: 33106278

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA (OBTA)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 32119972

Group type: EXPERIMENTAL
Intervention: dr. Bart app
Number of subjects: 427

Group type: COMPARATOR
Intervention: usual care
Number of subjects: 427
Study: 35180478

Group type: EXPERIMENTAL
Intervention: 10+ hours time in bed (TIB)
Number of subjects: 12

Group type: COMPARATOR
Intervention: 8 hours time in bed (control)
Number of subjects: 12
Study: 33761870

Group type: EXPERIMENTAL
Intervention: Levamisole
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 36443490

Group type: EXPERIMENTAL
Intervention: α-lactalbumin (40 g)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Zein (control beverage)
Number of subjects: 16

Group type: COMPARATOR
Intervention: corn-starch (control beverage)
Number of subjects: 16
Study: 33432991

Group type: EXPERIMENTAL
Intervention: Bilateral presbyopic LASIK (Custom‐Q mode) technique
Number of subjects: 28

Group type: COMPARATOR
Intervention: Contact lens monovision simulation
Number of subjects: 28
Study: 32800962

Group type: EXPERIMENTAL
Intervention: Exoskeletal-assisted walking
Number of subjects: 300000

Group type: COMPARATOR
Intervention: Standard care (wheelchair)
Number of subjects: 300000
Study: 35275404

Group type: EXPERIMENTAL
Intervention: Haptic simulator assistance
Number of subjects: 88

Group type: COMPARATOR
Intervention: No assistance (Control)
Number of subjects: 88
Study: 33817962

Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 102
Study: 33788483

Group type: EXPERIMENTAL
Intervention: Acupuncture at 'experienced ten acupoints' (Shangwan, Zhongwan, Xiawan, Qihai, Tianshu, Zusanli, Neiguan)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Irrelevant acupoint prescription (Feiyang, Heding, Yingu, Tianfu, Xiabai)
Number of subjects: 96
Study: 35907787

Group type: EXPERIMENTAL
Intervention: Targeted temperature management (TTM) for 24 hours
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Targeted temperature management (TTM) for 48 hours
Number of subjects: 114

Group type: COMPARATOR
Intervention: Both TTM durations (24h vs 48h)
Number of subjects: 114
Study: 33818443

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 80

Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 80
Study: 32641338

Group type: EXPERIMENTAL
Intervention: 6-month ART refills
Number of subjects: 36

Group type: COMPARATOR
Intervention: 2-month ART refills
Number of subjects: 36
Study: 35438754

Group type: EXPERIMENTAL
Intervention: Degarelix (1-time subcutaneous dose of 240 mg)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Degarelix
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 33384176

Group type: EXPERIMENTAL
Intervention: Knotless barbed sutures
Number of subjects: 40

Group type: COMPARATOR
Intervention: Vicryl sutures (Control)
Number of subjects: 40
Study: 36085150

Group type: EXPERIMENTAL
Intervention: Comprehensive diagnostic service (initial consultation, two-day diagnostics, follow-up consultations)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Waiting-list control group (comprehensive two-day diagnostic service and follow-up consultations)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Comprehensive diagnostic service
Number of subjects: 210

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 210
Study: 32223601

Group type: EXPERIMENTAL
Intervention: Targeted Medication Therapy Management (tMTM) intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (external samples)
Number of subjects: 0
Study: 34391194

Group type: EXPERIMENTAL
Intervention: Baby carrier intervention (n = 32 fathers) for three weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (n = 28 fathers) using a baby seat
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Baby carrier intervention
Number of subjects: 60
Study: 32040462

Group type: EXPERIMENTAL
Intervention: 0.8% hyaluronic acid
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no hyaluronic acid)
Number of subjects: 30
Study: 36168138

Group type: EXPERIMENTAL
Intervention: SMS delivery of Healthy Beginnings advice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Telephone delivery of Healthy Beginnings advice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0
Study: 33734000

Group type: EXPERIMENTAL
Intervention: Repetitive Transcranial Magnetic Stimulation (rTMS) and Bright Light Therapy (BLT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Repetitive Transcranial Magnetic Stimulation (rTMS)
Number of subjects: 80
Study: 32299768

Group type: EXPERIMENTAL
Intervention: Intermittent or continuous selumetinib (AZD6244, ARRY-142886), tremelimumab (anti-CTLA-4), and durvalumab (anti-PD-L1)
Number of subjects: 40
Study: 35401766

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) - 4 x 4-min bouts at 85%-95% maximal heart rate, interspersed with 3-min bouts at 50%-70% maximal heart rate, once a week for 12 months
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual care control group - health education
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 120
Study: 32502206

Group type: EXPERIMENTAL
Intervention: Digital recording system
Number of subjects: 48

Group type: COMPARATOR
Intervention: Analogue recording system
Number of subjects: 48
Study: 35703026

Group type: EXPERIMENTAL
Intervention: Responsive Parenting (RP) intervention
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 117
Study: 32086187

Group type: EXPERIMENTAL
Intervention: 200 mg of caffeine
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study: 36342178

Group type: EXPERIMENTAL
Intervention: Cryoballoon ablation
Number of subjects: 303

Group type: COMPARATOR
Intervention: Antiarrhythmic drug therapy
Number of subjects: 303
Study: 33404764

Group type: COMPARATOR
Intervention: hard-setting calcium hydroxide (Dycal) (control group)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: bioactive tricalcium silicate (Biodentine)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: resin-based tricalcium silicate (TheraCal LC)
Number of subjects: 109
Study: 34549864

Group type: EXPERIMENTAL
Intervention: EMPOWER intervention via telephone counseling for 7 weeks
Number of subjects: 94

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 94
Study: 32675474

Group type: EXPERIMENTAL
Intervention: Isometric handgrip exercise (IHE) at 20% of maximal voluntary isometric contraction (MVIC) for 2 minutes
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 31
Study: 37721420

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 33392885

Group type: EXPERIMENTAL
Intervention: Positive anti‐β2‐GPI antibody
Number of subjects: 64

Group type: COMPARATOR
Intervention: Negative anti‐β2‐GPI antibody
Number of subjects: 64
Study: 36197253

Group type: EXPERIMENTAL
Intervention: Epidural analgesia (EA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non-epidural analgesia (NEA)
Number of subjects: 60
Study: 33775930

Group type: EXPERIMENTAL
Intervention: Proximal optimisation technique (POT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Kissing balloon technique (KBT)
Number of subjects: 120
Study: 33249424

Group type: EXPERIMENTAL
Intervention: CsA alone
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: CsA+MMF
Number of subjects: 497
Study: 35144668

Group type: EXPERIMENTAL
Intervention: Custom insoles
Number of subjects: 139

Group type: COMPARATOR
Intervention: Sham insoles
Number of subjects: 139
Study: 32421521

Group type: EXPERIMENTAL
Intervention: Laryngeal tube (LT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Bag mask ventilation (BMV)
Number of subjects: 20
Study: 616442377

Group type: EXPERIMENTAL
Intervention: Pain training program
Number of subjects: 77

Group type: COMPARATOR
Intervention: Visual support training
Number of subjects: 77
Study: 35879693

Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART) initiation
Number of subjects: 302
Study: 32776518

Group type: EXPERIMENTAL
Intervention: High-flow nasal therapy with closed mouth
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High-flow nasal therapy with open mouth
Number of subjects: 20

Group type: COMPARATOR
Intervention: Closed mouth
Number of subjects: 20

Group type: COMPARATOR
Intervention: Open mouth
Number of subjects: 20
Study: 35506888

Group type: EXPERIMENTAL
Intervention: Paediatric Autism Communication Therapy (PACT) - 12 sessions
Number of subjects: 160

Group type: COMPARATOR
Intervention: Community support as usual plus psychoeducation - 5 months
Number of subjects: 160
Study: 34236004

Group type: EXPERIMENTAL
Intervention: DPP‐GLB lifestyle intervention
Number of subjects: 305
Study: 36191485

Group type: EXPERIMENTAL
Intervention: 200 mg tea polyphenols (TP)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: 100 mg tea polyphenols (TP)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: 50 mg tea polyphenols (TP)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: EGCG/EC intervention
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: EGCG/EC supplementation
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: EGCG supplementation
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 65
Study: 34274136

Group type: EXPERIMENTAL
Intervention: Cabazitaxel (25 mg/m2 plus prednisone and granulocyte colony-stimulating factor)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Abiraterone/enzalutamide
Number of subjects: 255
Study: 34013650

Group type: EXPERIMENTAL
Intervention: Erythritol powder air polishing and ultrasonic instrumentation (EPAP+UI)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Ultrasonic debridement and polishing (UD+P)
Number of subjects: 13
Study: 33449432

Group type: EXPERIMENTAL
Intervention: Parent training intervention supporting home oral hygiene and dental visits
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Hispanic caregivers
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Caregivers living alone with children
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Multivariable analysis
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Overall findings
Number of subjects: 118
Study: 35605339

Group type: EXPERIMENTAL
Intervention: Accelerated rehabilitation pathway
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control rehabilitation pathway
Number of subjects: 44
Study: 34779349

Group type: EXPERIMENTAL
Intervention: Exercise group (1 year of 150 min weekly combined strength and endurance exercise)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 137

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 137
Study: 34715757

Group type: EXPERIMENTAL
Intervention: FIR (Far Infrared Radiation)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no FIR)
Number of subjects: 20
Study: 33517741

Group type: EXPERIMENTAL
Intervention: US-guided injection
Number of subjects: 90

Group type: COMPARATOR
Intervention: Blind injection
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 90
Study: 32023617

Group type: EXPERIMENTAL
Intervention: Tongue-strengthening exercises 3 times per week (EX3)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Tongue-strengthening exercises 5 times per week (EX5)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 20
Study: 35551484

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 100

Group type: COMPARATOR
Intervention: Non-surgical treatment
Number of subjects: 100
Study: 33191260

Group type: EXPERIMENTAL
Intervention: Aspirin (ASA) 650 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Acetaminophen (APAP) 650 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35855580

Group type: EXPERIMENTAL
Intervention: Brief online gatekeeper training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 33568208

Group type: EXPERIMENTAL
Intervention: Decision aid along with decision coaching on PSA screening from a community health worker (CHW)
Number of subjects: 228

Group type: COMPARATOR
Intervention: Decision aid along with CHW-led interaction on modifying dietary and lifestyle (attention control)
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Decision coaching intervention
Number of subjects: 228
Study: 32673262

Group type: EXPERIMENTAL
Intervention: mHealth intervention with automated SMS messages for TB contact investigation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no automated SMS messages)
Number of subjects: 0
Study: 35570153

Group type: EXPERIMENTAL
Intervention: Two-catheter concepts (TCC) by Judkins catheter
Number of subjects: 300

Group type: COMPARATOR
Intervention: One-catheter concepts (OCC) by Tiger II and BLK catheters
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Two-catheter concepts (TCC)
Number of subjects: 300

Group type: COMPARATOR
Intervention: One-catheter concepts (OCC)
Number of subjects: 300
Study: 32639610

Group type: EXPERIMENTAL
Intervention: Graft tensioning protocol
Number of subjects: 0
Study: 35331943

Group type: EXPERIMENTAL
Intervention: smartphone App delivery of caregiver skills with Mentalizing Imagery Therapy (MIT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: smartphone App delivery of caregiver skills without MIT (control condition)
Number of subjects: 120
Study: 35026055

Group type: EXPERIMENTAL
Intervention: Text message intervention (22 fortnightly messages over approximately 10 months)
Number of subjects: 279
Study: 34341868

Group type: EXPERIMENTAL
Intervention: HFIT management (herbicides, fertilizers, irrigation, tillage)
Number of subjects: 303

Group type: COMPARATOR
Intervention: No management (control group)
Number of subjects: 303
Study: 32959434

Group type: EXPERIMENTAL
Intervention: Model I: local standard of care with women in general ART services and infants at well-baby clinics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Model II: integrated maternal and child care approach during the postpartum breastfeeding period
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Model III: referral of women directly to community adherence clubs with infants receiving care at well-baby clinics
Number of subjects: 0
Study: 35941566

Group type: EXPERIMENTAL
Intervention: Gemcitabine alone
Number of subjects: 40

Group type: COMPARATOR
Intervention: Gemcitabine plus SBRT
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both arms
Number of subjects: 40
Study: 33811034

Group type: EXPERIMENTAL
Intervention: Subcutaneous denosumab 60 mg every 6 months for 24 months
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo every 6 months for 24 months
Number of subjects: 98
Study: 32640945

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 1337

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 1337
Study: 36064438

Group type: EXPERIMENTAL
Intervention: AutoKinetics dosing for ciprofloxacin
Number of subjects: 252

Group type: COMPARATOR
Intervention: Standard dosing for ciprofloxacin (Control)
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: AutoKinetics dosing for other antibiotics (meropenem, vancomycin, ceftriaxone)
Number of subjects: 252

Group type: COMPARATOR
Intervention: AutoKinetics dosing and Standard dosing (Control)
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Higher dosing (AutoKinetics)
Number of subjects: 252
Study: 32901255

Group type: EXPERIMENTAL
Intervention: Tolvaptan 15 mg/day
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Tolvaptan 30 mg/day
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Tolvaptan (both dosages)
Number of subjects: 124
Study: 35638505

Group type: EXPERIMENTAL
Intervention: High incipient informal social control (ISC)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Perceived informal social control (ISC)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Bystander legitimacy
Number of subjects: 210
Study: 35104279

Group type: EXPERIMENTAL
Intervention: Aspirin 80 mg daily
Number of subjects: 387

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 387
Study: 32841462

Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine (LDX)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33332403

Group type: EXPERIMENTAL
Intervention: Mindfulness practice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active-control (music listening)
Number of subjects: 0
Study: 36404655

Group type: EXPERIMENTAL
Intervention: Endoscopic surgery (ENPG)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Intensity-modulated radiotherapy (IMRT)
Number of subjects: 200
Study: 36035299

Group type: EXPERIMENTAL
Intervention: High-risk group based on FRlncRNA signature
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-risk group based on FRlncRNA signature
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Risk model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-risk group
Number of subjects: 0
Study: 33025656

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg for 1 year
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Open-label high-intensity statin after 1 year
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: LDL levels more than 90 mg/dl in the first year
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: LDL levels less than 90 mg/dl in the first year
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Higher mean LDL levels during the first postoperative year
Number of subjects: 173
Study: 35610702

Group type: EXPERIMENTAL
Intervention: LLLT GaAlAs 940 nm, 5 J/cm2 immediately after surgery and every other day for ten days
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham irradiation
Number of subjects: 16
Study: 34390392

Group type: EXPERIMENTAL
Intervention: Allopurinol 300 mg
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 33048462

Group type: EXPERIMENTAL
Intervention: NobelReplace Tapered implants (Nobel Biocare, Sweden)
Number of subjects: 43

Group type: COMPARATOR
Intervention: NobelSpeedy implants (Nobel Biocare, Sweden)
Number of subjects: 43